Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) Forward Dividend Yield % : 0.00% (As of May. 27, 2025)

View and export this data going back to 2012. Start your Free Trial

What is Beijing Bohui Innovation Biotechnology Group Co Forward Dividend Yield %?

As of today (2025-05-27), the Forward Annual Dividend Yield of Beijing Bohui Innovation Biotechnology Group Co is 0.00%.

As of today (2025-05-27), the Trailing Annual Dividend Yield of Beijing Bohui Innovation Biotechnology Group Co is 0.00%.

SZSE:300318's Forward Dividend Yield % is not ranked ^*
in the Biotechnology industry.
Industry Median: 1.39
* Ranked among companies with meaningful Forward Dividend Yield % only.

Beijing Bohui Innovation Biotechnology Group Co's Dividends per Share for the three months ended in Mar. 2025 was ¥0.00.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Beijing Bohui Innovation Biotechnology Group Co was -42.80% per year. The lowest was -45.00% per year. And the median was -43.90% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Competitive Comparison of Beijing Bohui Innovation Biotechnology Group Co's Forward Dividend Yield %

For the Biotechnology subindustry, Beijing Bohui Innovation Biotechnology Group Co's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Beijing Bohui Innovation Biotechnology Group Co's Forward Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Beijing Bohui Innovation Biotechnology Group Co's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Beijing Bohui Innovation Biotechnology Group Co's Forward Dividend Yield % falls into.

Save Embed

;

Save Embed

;

Beijing Bohui Innovation Biotechnology Group Co Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Beijing Bohui Innovation Biotechnology Group Co Forward Dividend Yield % Related Terms

Thank you for viewing the detailed overview of Beijing Bohui Innovation Biotechnology Group Co's Forward Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Beijing Bohui Innovation Biotechnology Group Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Beijing Bohui Innovation Biotechnology Group Co Ltd (SZSE:300318) » Definitions » Forward Dividend Yield %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Block G Jingxinyuan, NO.25 Jia Beiwucun Road, Haidian, Beijing, CHN, 100097

Website

http://www.bohui-tech.com

Beijing Bohui Innovation Biotechnology Group Co Ltd is a high-tech biomedical enterprise integrating R&D, production, sales, and after-sales service. The company focuses on the research and development, production, sales, and after-sales services of in vitro diagnostic products. The Company's business involved two segments: inspection and testing and biological products. The Biological segment generated the majority of its revenue which engaged in the research and development, production, and sales of blood products, the product range covers human blood albumin, human immunoglobulin, and human coagulation factor three categories of multiple varieties, basically covering the important varieties of blood products.

Executives

Niu Shu Hui	Executives
Di Xiao Feng	Director
Yang Qi	Director
Lu Xin Qun	Directors, executives
Zhang Lei	Director
Wan Zhang Geng	Executives
Song Rui	Directors, executives

Beijing Bohui Innovation Biotechnology Group Co Headlines

No Headlines